France Reveals The Drugs That Are Most Likely To Require Post-Market RWE Studies

A study from the health technology assessment department of France’s national health agency, HAS, has identified which pharmaceutical products are most likely to receive a request for post-market studies. The agency hopes this information will aid in companies’ forward planning.